Marken, a UPS Healthcare company, has expanded its global network to support increased demand for its clinical drug supply chain services, particularly for cell and gene clinical trials.   Plans for the remainder of 2021 and 2022 will support accelerated demand for mRNA therapies, cell and gene therapies, early access and managed access programs. Expansion plans include new locations, expanded cold chain services and packaging solutions.   “We are accelerating the expansion of our clinical suppl...